Winterlight Labs
Latest round
- Series A
Last raised
- Nov 2019
Total raised
- $5.7M
Investors
- 5
About Winterlight Labs
Winterlight Labs Inc.Founded in 2015 and headquartered in Toronto, Canada, Winterlight Labs Inc. offers innovative cognitive assessment solutions. The company was involved in a significant pivot when it was acquired by Cambridge Cognition Limited in January 2023 for GBP 7 million, which included GBP 3 million in cash and GBP 4 million in shares. The acquisition enhances Cambridge Cognition's offerings with Winterlight's speech-based cognitive assessment technology. Winterlight has completed a total of 4 deals, with its most recent deal occurring in January 2023.Winterlight Labs specializes in innovative cognitive assessment solutions through its proprietary tablet-based technology, which analyzes speech to detect cognitive impairments associated with conditions such as dementia and mental illness. The core offering, the Winterlight Assessment, utilizes advanced speech analysis to extract digital biomarkers from brief speech samples, facilitating a fast and objective evaluation process that is particularly suited for use in life science research, clinical settings, and senior care. The technology has garnered trust from five of the top ten life sciences companies and is currently integrated into various clinical trials, enabling researchers and clinicians to monitor disease progression and treatment responses effectively.Winterlight Labs generates revenue through partnerships and collaborations with leading life sciences companies and research institutions. Its business model primarily revolves around subscription-based access to its speech analysis platform, allowing clients to utilize the technology for various clinical assessments and trials. Clients engage Winterlight for services including site onboarding, data collection, and analysis of speech data, which supports their research initiatives. While specific pricing structures for individual products or services are not disclosed, the company’s flagship offering, the Winterlight Assessment, is central to its revenue model, driving transactions across both B2B partnerships and direct client engagement in clinical research settings.Following its recent acquisition, Winterlight Labs plans to focus on enhancing its product offerings and expanding its market reach. The integration with Cambridge Cognition Limited will facilitate the development of new speech analysis tools that are set to launch in the upcoming year. Winterlight aims to broaden its client base internationally, particularly targeting Europe and the United States by the end of 2024.
Who invested in Winterlight Labs
5 investors across 3 rounds
See all investors in Winterlight Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Winterlight Labs
Who invested in Winterlight Labs?
Winterlight Labs has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Winterlight Labs raised?
Winterlight Labs has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Winterlight Labs last raise money?
Winterlight Labs's most recent round on record is a Series A, in Nov 2019.
What does Winterlight Labs do?
Winterlight Labs is a software company.
Where is Winterlight Labs headquartered?
Winterlight Labs is headquartered in Toronto, Canada.
Which VCs invest in companies like Winterlight Labs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Winterlight Labs's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Winterlight Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.